Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
Blood. 2021 Apr 8;137(14):1895-1904. doi: 10.1182/blood.2020005216.
Chronic lymphocytic leukemia (CLL) major stereotyped subset 2 (IGHV3-21/IGLV3-21, ∼2.5% of all cases of CLL) is an aggressive disease variant, irrespective of the somatic hypermutation (SHM) status of the clonotypic IGHV gene. Minor stereotyped subset 169 (IGHV3-48/IGLV3-21, ∼0.2% of all cases of CLL) is related to subset 2, as it displays a highly similar variable antigen-binding site. We further explored this relationship through next-generation sequencing and crystallographic analysis of the clonotypic B-cell receptor immunoglobulin. Branching evolution of the predominant clonotype through intraclonal diversification in the context of ongoing SHM was evident in both heavy and light chain genes of both subsets. Molecular similarities between the 2 subsets were highlighted by the finding of shared SHMs within both the heavy and light chain genes in all analyzed cases at either the clonal or subclonal level. Particularly noteworthy in this respect was a ubiquitous SHM at the linker region between the variable and the constant domain of the IGLV3-21 light chains, previously reported as critical for immunoglobulin homotypic interactions underlying cell-autonomous signaling capacity. Notably, crystallographic analysis revealed that the IGLV3-21-bearing CLL subset 169 immunoglobulin retains the same geometry and contact residues for the homotypic intermolecular interaction observed in subset 2, including the SHM at the linker region, and, from a molecular standpoint, belong to a common structural mode of autologous recognition. Collectively, our findings document that stereotyped subsets 2 and 169 are very closely related, displaying shared immunoglobulin features that can be explained only in the context of shared functional selection.
慢性淋巴细胞白血病(CLL)主要定型亚组 2(IGHV3-21/IGLV3-21,约占所有 CLL 病例的 2.5%)是一种侵袭性疾病变体,与克隆型 IGHV 基因的体细胞超突变(SHM)状态无关。次要定型亚组 169(IGHV3-48/IGLV3-21,约占所有 CLL 病例的 0.2%)与亚组 2 相关,因为它显示出高度相似的可变抗原结合位点。我们通过下一代测序和克隆型 B 细胞受体免疫球蛋白的晶体分析进一步探索了这种关系。在持续的 SHM 背景下,通过克隆内多样化,主要克隆型的分支进化在两个亚组的重链和轻链基因中都很明显。在两个亚组之间发现共享 SHM,这突出了它们之间的分子相似性,在所有分析的病例中,无论是在克隆或亚克隆水平,在重链和轻链基因中都发现了共享 SHM。在这方面特别值得注意的是,在 IGLV3-21 轻链的可变区和恒定区之间的连接区普遍存在一个 SHM,以前报道称该 SHM 对细胞自主信号传导能力的免疫球蛋白同种型相互作用至关重要。值得注意的是,晶体分析表明,亚组 169 携带 IGLV3-21 的 CLL 免疫球蛋白保留了与亚组 2 观察到的同种型分子间相互作用相同的几何形状和接触残基,包括连接区的 SHM,从分子角度来看,属于同源识别的共同结构模式。总的来说,我们的研究结果表明定型亚组 2 和 169 非常密切相关,具有共享的免疫球蛋白特征,这些特征只能在共享功能选择的背景下解释。